Lv1
28 积分 2025-05-08 加入
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria
2个月前
已完结
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
2个月前
已完结
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder
4个月前
已关闭
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
4个月前
已完结
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
4个月前
已完结
Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder
4个月前
已完结
A randomized, prospective, active-controlled study comparing intramuscular long-acting paliperidone palmitate versus oral antipsychotics in patients with schizophrenia at risk of violent behavior
4个月前
已完结
Disease relapse, all-cause mortality, and adverse events associated with long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia in Hong Kong: a population-based within-subject analysis
4个月前
已完结
皖公网安备34019202002308
